Figure 6.
Haemolytic effects of the PLGA nanocapsule and of the PLGA nanocapsule containing 15d-PGJ2 suspensions (0.15% haematocrit, pH 7.4, 37°C, n = 6 per group).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.